Related Experiment Videos
Estimating the dosage of ribavirin aerosol according to age and other variables
V Knight1, C P Yu, B E Gilbert
1Department of Microbiology and Immunology, Baylor College of Medicine, Houston, Texas 77030.
Insights
This study presents a method for calculating aerosolized ribavirin dosage based on age, using a computer model. It accounts for factors like sex, weight, and fever to optimize respiratory tract drug delivery.
Area of Science:
- Pharmacokinetics
- Respiratory Medicine
- Computational Modeling
Background:
- Accurate dosing of aerosolized medications like ribavirin is crucial for effective treatment, especially in diverse age groups.
- Previous methods may not adequately account for physiological variations influencing drug deposition.
Purpose of the Study:
- To develop and validate a method for estimating age-specific dosages of aerosolized ribavirin.
- To refine dosage calculations by incorporating factors affecting particle deposition in the respiratory tract.
Main Methods:
- Utilized a computer model simulating particle deposition in the respiratory system.
- Incorporated corrections for patient age, sex, body weight, fever, and tracheal intubation status.
- Analyzed deposition rates across different age groups from three months to 25 years.
Main Results:
- Respiratory tract deposition of ribavirin aerosol was higher in infants (1.8 mg/kg/hr) than adults (0.9 mg/kg/hr).
- Females and older women showed approximately 7% less deposition per kilogram compared to males.
- Fever increased deposition by about 9% per degree Celsius (5% per degree Fahrenheit).
- Tracheal intubation altered drug distribution, favoring lung delivery and bypassing the nasopharynx.
Conclusions:
- The developed method provides a more precise approach to dosing aerosolized ribavirin across pediatric and young adult populations.
- Individual physiological factors significantly influence ribavirin deposition, necessitating personalized dosage adjustments.
- This model aids in optimizing therapeutic efficacy and minimizing potential toxicity of inhaled ribavirin.
Abstract:
We describe a method for estimating the dosage of aerosolized ribavirin according to age. The calculations were determined by using a computer model of particle deposition, and corrections are described for sex, body weight, fever, and tracheal intubation. Respiratory tract deposition in infants, after they inhaled an aerosol containing 200 micrograms of ribavirin/L, was 1.8 mg/kg per hour; in adults the deposition was 0.9 mg/kg per hour. Adolescent females and older women have less (7%/kg) respiratory tract deposition than do males. Fever will increase deposition about 9%/degree Centigrade (5%/degree Fahrenheit) for each degree of increase above normal temperature. Tracheal intubation will deliver relatively more drug to the lung and no drug to the nasopharynx. Our report shows the regional and total deposition of inhaled ribavirin aerosol in the respiratory tracts of persons in different age-groups from three months to 25 y.